Karim Si‐Tayeb

ORCID: 0000-0003-4599-7441
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pluripotent Stem Cells Research
  • Liver physiology and pathology
  • CRISPR and Genetic Engineering
  • Pancreatic function and diabetes
  • Lipoproteins and Cardiovascular Health
  • Tissue Engineering and Regenerative Medicine
  • Renal and related cancers
  • 3D Printing in Biomedical Research
  • Neuroscience and Neural Engineering
  • Biomedical Ethics and Regulation
  • Peptidase Inhibition and Analysis
  • Protease and Inhibitor Mechanisms
  • RNA Research and Splicing
  • Genomics and Rare Diseases
  • Erythrocyte Function and Pathophysiology
  • Cardiac electrophysiology and arrhythmias
  • Lipid metabolism and disorders
  • Cancer Mechanisms and Therapy
  • Endoplasmic Reticulum Stress and Disease
  • Cardiac Ischemia and Reperfusion
  • Anesthesia and Neurotoxicity Research
  • Hemoglobinopathies and Related Disorders
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • PI3K/AKT/mTOR signaling in cancer
  • Skin and Cellular Biology Research

Institut du Thorax
2015-2025

Centre National de la Recherche Scientifique
2013-2025

Inserm
2013-2025

Nantes Université
2013-2025

Centre Hospitalier Universitaire d'Angers
2021

Matrix Research (United States)
2014

Université Paris-Sud
2012-2013

Université Paris-Saclay
2013

Charité - Universitätsmedizin Berlin
2013

Bicêtre Hospital
2012-2013

There exists a worldwide shortage of donor livers available for orthotropic liver transplantation and hepatocyte therapies. In addition to their therapeutic potential, primary human hepatocytes facilitate the study molecular genetic aspects hepatic disease development provide platform drug toxicity screens identification novel pharmaceuticals with potential treat wide array metabolic diseases. The demand hepatocytes, therefore, heavily outweighs availability. As an alternative using as...

10.1002/hep.23354 article EN Hepatology 2009-10-01

Abstract Background The use of lentiviruses to reprogram human somatic cells into induced pluripotent stem (iPS) could limit their therapeutic usefulness due the integration viral DNA sequences genome recipient cell. Recent work has demonstrated that iPS can be generated using episomal plasmids, excisable transposons, adeno or sendai viruses, mRNA, recombinant proteins. While these approaches offer an advance, protocols have some drawbacks. Commonly procedures require either subcloning...

10.1186/1471-213x-10-81 article EN cc-by BMC Developmental Biology 2010-08-03

The availability of pluripotent stem cells offers the possibility using such to model hepatic disease and development. With this in mind, we previously established a protocol that facilitates differentiation both human embryonic induced into share many characteristics with hepatocytes. use highly defined culture conditions avoidance feeder or embryoid bodies allowed synchronous reproducible occur. towards hepatocyte-like fate appeared recapitulate developmental stages normally associated...

10.1242/dev.062547 article EN Development 2011-08-19

Abstract Background To maintain pluripotency of human embryonic stem (huES) cells in feeder-free culture it has been necessary to provide a Matrigel substratum, which is complex poorly defined extracellular matrices and growth factors derived from mouse Engelbreth-Holm-Swarm sarcoma cells. Culture under ill-defined conditions can inhibit the effectiveness maintaining pluripotent state reduce reproducibility differentiation protocols. Moreover recent batches have found be contaminated with...

10.1186/1471-213x-10-60 article EN cc-by BMC Developmental Biology 2010-06-02

Elevated levels of low-density lipoprotein cholesterol (LDL-C) in plasma are a major contributor to cardiovascular disease, which is the leading cause death worldwide. Genome-wide association studies (GWAS) have identified 95 loci that associate with control lipid/cholesterol metabolism. Although GWAS results highly provocative, direct analyses contribution specific allelic variations regulating LDL-C has been challenging due difficulty accessing appropriate cells from affected patients. The...

10.1002/hep.25871 article EN Hepatology 2012-05-31

Secondary erythrocytosis often results from conditions that cause tissue hypoxia or an improper increase in erythropoietin (EPO) production. EPO, the major regulator of erythropoiesis, has a complex and tightly regulated expression during development, with liver-to-kidney switch shortly after birth. We identified six families was associated circulating EPO levels within normal range characterized as novel molecular functional entity. investigated effect pathogenic variants using...

10.1056/nejmoa2414954 article EN New England Journal of Medicine 2025-05-01

Loss of the nuclear hormone receptor hepatocyte factor 4α (HNF4α) in hepatocytes results a complex pleiotropic phenotype that includes block differentiation and severe disruption to liver function. Recent analyses have shown hepatic gene expression is severely affected by absence HNF4α, with 567 genes reduced ≥2.5-fold (P ≤ 0.05) Hnf4α−/− fetal livers. Although many these are direct targets, HNF4α has also been regulate other transcription factors, this raises possibility dependence on for...

10.1002/hep.22439 article EN Hepatology 2008-05-30

Background Human genetically inherited cardiac diseases have been studied mainly in heterologous systems or animal models, independent of patients' genetic backgrounds. Because sources human cardiomyocytes ( CM s) are extremely limited, the use urine samples to generate induced pluripotent stem cell–derived s would be a noninvasive method identify dysfunctions that lead pathologies within specific The objective was validate CMs differentiated from urine‐derived (UhiPS) cells as new cellular...

10.1161/jaha.115.002159 article EN cc-by-nc-nd Journal of the American Heart Association 2015-09-16

ABSTRACT Proprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, loss-of-function (LOF) have cardio-protective effect in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations the currently available cellular models preclude deciphering consequences mutation further. We...

10.1242/dmm.022277 article EN cc-by Disease Models & Mechanisms 2015-12-18

Abstract Over a decade after their discovery, induced pluripotent stem cells (iPSCs) have become major biological model. The iPSC technology allows generation of from somatic bearing any genomic background. challenge ahead us is to translate human iPSCs (hiPSCs) protocols into clinical treatment. To do so, we need improve the quality hiPSCs produced. In this study report reprogramming multiple patient urine-derived cell lines with mRNA reprogramming, which, date, one fastest and most...

10.1038/s41598-018-32645-2 article EN cc-by Scientific Reports 2018-09-19

Abstract Intra‐hepatic invasion is a key feature of hepatocellular carcinoma (HCC) progression. We have shown that human liver myofibroblasts induce HCC cells through Matrigel, via the secretion hepatocyte growth factor (HGF). In our study, we investigated role matrix metalloproteinases (MMP) in HGF‐induced invasion. Marimastat, synthetic MMP inhibitor, dose‐dependently decreased HepG2 with maximum 82.7 ± 13.3% at 20 μM. TIMP‐2, natural up to 51.2 11.2% 200 ng/ml. To determine target for...

10.1002/ijc.1595 article EN International Journal of Cancer 2001-12-13

Human embryonic stem cell (hESC)-derived cardiomyocytes potentially represent a powerful experimental model complementary to myocardium obtained from patients that is relatively inaccessible for research purposes. We tested whether anesthetic-induced preconditioning (APC) with isoflurane elicits competent protective mechanisms in hESC-derived against oxidative stress be used as of human studying preconditioning.H1 hESC line was differentiated into using growth factors activin A and bone...

10.1097/aln.0b013e3181eff6b7 article EN Anesthesiology 2010-09-04

We recently reported that, following induction of clumps pluripotent H1 human embryonic stem cells (hESCs) with activin-A and Bmp4 in defined medium for 5 days, widespread differentiation rhythmically contracting cardiomyocytes occurs within 3–4 weeks. In this study, the same approach was used to assess whether induced (hiPSCs), which may theoretically provide an unlimited source patient-matched transplantation therapy, can similarly undergo cardiomyocyte differentiation. Differentiation...

10.3727/096368912x653165 article EN Cell Transplantation 2012-08-03

Abstract The liver plays a key role in the metabolism of lipoproteins, controlling both production and catabolism. To accelerate development new lipid‐lowering therapies humans, it is essential to have relevant vitro study model available. current hepatocyte‐like cells (HLCs) models derived from hiPSC can be used many genetically driven diseases but require further improvement better recapitulate complexity functions. Here, we aimed improve maturation HLCs using three‐dimensional (3D)...

10.1002/btm2.10659 article EN cc-by Bioengineering & Translational Medicine 2024-03-16

Background: Atherosclerotic cardiovascular disease is the main cause of mortality worldwide and strongly influenced by circulating low-density lipoprotein (LDL) cholesterol levels. Only a few genes causally related to plasma LDL levels have been identified so far, only 1 gene, ANGPTL3 , has combined hypocholesterolemia. Here, our aim was elucidate genetic origin an unexplained hypocholesterolemia inherited in 4 generations French family. Methods: Using next-generation sequencing, we novel...

10.1161/circulationaha.121.057978 article EN cc-by-nc-nd Circulation 2022-09-06

Hereditary erythrocytosis is a rare hematologic disorder characterized by an excess of red blood cell production. Here we describe European collaborative study involving collection 2,160 patients with sequenced in ten different laboratories. We focused our on the EGLN1 gene and identified 39 germline missense variants including one deletion 47 probands. encodes PHD2 prolyl 4-hydroxylase, major inhibitor hypoxia-inducible factor. performed comprehensive to evaluate causal role variants: (i)...

10.3324/haematol.2023.282913 article EN cc-by-nc Haematologica 2023-06-15

Abstract Background Human pluripotent stem cells (hPSCs) hold great promise for applications in regenerative medicine. However, the safety of cell therapy using differentiated hPSC derivatives must be improved through methods that will permit transplantation homogenous populations a specific type. To date, purification progenitors and mature generated from either embryonic or induced remains challenging with use conventional methods. Results We used lentivectors encoding green fluorescent...

10.1186/1741-7007-11-86 article EN cc-by BMC Biology 2013-07-19

Abstract Human induced pluripotent stem (hiPS) cell technology has already revolutionized some aspects of fundamental and applied research such as study disease mechanisms pharmacology screening. The first clinical trial using hiPS cell‐derived cells began in Japan, only 10 years after the publication proof‐of concept article. In this exciting context, strategies to generate have evolved quickly, tending towards non‐invasive protocols sample somatic combined with “safer” reprogramming...

10.1002/cphg.26 article EN Current Protocols in Human Genetics 2017-01-01

This manuscript proposes an efficient and reproducible protocol for the generation of genetically modified human induced pluripotent stem cells (hiPSCs) by genome editing using CRISPR-Cas9 technology. Here, we describe experimental strategy generating knockout (KO) knockin (KI) clonal populations hiPSCs single-cell sorting flow cytometry. We efficiently achieved up to 15 kb deletions, molecular tag insertions, single-nucleotide in hiPSCs. emphasize efficacy this approach terms cell culture...

10.1016/j.xpro.2022.101680 article EN cc-by-nc-nd STAR Protocols 2022-09-16
Coming Soon ...